GSK Overview

  • Status
  • Public

  • Employees
  • 70,200


  • Stock Symbol
  • GSK

Stock Symbol

  • Investments
  • 140

  • Share Price
  • $22.52
  • (As of Friday Closing)

GSK General Information


In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, cancer, and antiviral, as well as vaccines. GSK uses joint ventures to gain additional scale in certain markets like HIV.

Contact Information

Formerly Known As
Ownership Status
Publicly Held
Financing Status
Primary Industry
Other Industries
Drug Discovery
Stock Exchange
Corporate Office
  • 980 Great West Road
  • Brentford
  • Middlesex TW8 9GS
  • England, United Kingdom
+44 020 0000 0000

GSK Timeline

Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

GSK Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$22.52 $22.62 $16.59 - $23.14 $93.4B 4.14B 7.65M $1.29

GSK Financials Summary

In Thousands,
TTM 31-Mar-2024 FY 2023 31-Dec-2023 FY 2022 31-Dec-2022 FY 2021 31-Dec-2021
EV 104,021,312 91,903,017 87,164,139 147,255,446
Revenue 38,624,398 37,698,886 36,140,896 33,960,396
EBITDA 10,494,176 11,230,857 10,562,252 8,902,640
Net Income 5,634,086 6,125,696 18,432,794 6,029,978
Total Assets 73,870,064 75,166,563 72,788,663 106,760,331
Total Debt 22,437,128 22,953,159 25,398,458 32,624,774
Public Fundamental Data provided by Morningstar, Inc. disclaimer

GSK Valuation & Funding

Deal Type Date Amount Valuation/
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore GSK‘s full profile, request access.

Request a free trial

GSK Comparisons

HQ Location
Total Raised
Post Valuation
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might acros
Middlesex, United Kingdom
70,200 As of 2023
000000000 000.00


t in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint
Cambridge, United Kingdom
00000 As of 0000
000000000 00 000.00


tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, qui
Basel, Switzerland
00000 As of 0000
000000000 0000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

GSK Competitors (33)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
AstraZeneca Formerly PE-Backed Cambridge, United Kingdom 00000 000.00 000000000 00 000.00
Novartis Corporation Basel, Switzerland 00000 0000 000000000 0000
Merck & Co. Corporation Rahway, NJ 00000 000.00 000000000 000.00
Pfizer (Pharmaceuticals) Corporation New York, NY 00000 000.00 0000 000.00
Emergent BioSolutions Corporation Gaithersburg, MD 0000 00.000 000000000 00 00.000
You’re viewing 5 of 33 competitors. Get the full list »

GSK Patents

GSK Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
GB-202403099-D0 Novel methods for the purification of oligonucleotides Pending 04-Mar-2024
GB-202400824-D0 Compounds Pending 22-Jan-2024
GB-202400829-D0 Compounds Pending 22-Jan-2024
GB-202400832-D0 Compounds Pending 22-Jan-2024
GB-202400835-D0 Compounds Pending 22-Jan-2024
To view GSK’s complete patent history, request access »

GSK Executive Team (144)

Name Title Board Seat Contact Info
Emma Walmsley Chief Executive Officer & Board Member
David Redfern Chief Strategy Officer & President, Corporate Development
Julie Brown Chief Financial Officer & Board Member
Shobie Ramakrishnan Chief Digital and Technology Officer
Diana Conrad Chief People Officer & Chief Human Resources Officer
You’re viewing 5 of 144 executive team members. Get the full list »

GSK Board Members (31)

Name Representing Role Since
0000 0000 00 Self Independent Non-Executive Director 000 0000
0000000 00000000 GSK Member of Corporate Administration & Transactions, Chairman of Audit & Risk and Senior Independent Non-Executive Director 000 0000
0000 00000000 GSK Chief Executive Officer & Board Member 000 0000
000 000000 00 GSK Non-Executive Director 000 0000
00000 00000 Self Board Member 000 0000
You’re viewing 5 of 31 board members. Get the full list »

GSK Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

GSK Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore GSK‘s full profile, request access.

Request a free trial

GSK Investments & Acquisitions (140)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Elegen 14-May-2024 00000 0000 0000 Biotechnology
BioVersys 07-May-2024 00000 0000 000.00 Drug Discovery
Aiolos Bio 15-Feb-2024 0000000000 00.00 Biotechnology 0000 0000
Bellus Health 28-Jun-2023 0000000000 000 Drug Discovery 0000 0000
WaVe Life Sciences 13-Dec-2022 PIPE 00.00 Drug Discovery 0000 0000
You’re viewing 5 of 140 investments and acquisitions. Get the full list »

GSK Subsidiaries (9)

Company Name Industry Location Founded
Aiolos Bio Biotechnology Boston, MA 2023
Affinivax Drug Discovery Cambridge, MA 0000
Action Potential Venture Capital Corporate Venture Capital Cambridge, MA 0000
Fonds De Pension Gsk Biologicals Aam Corporate Pension Rixensart, Belgium 0000
Genelabs Technologies Pharmaceuticals Redwood City, CA 0000
You’re viewing 5 of 9 subsidiaries. Get the full list »


Risk Overview

Risk Rating

Updated April, 27, 2024

16.77 | Low Risk

Risk Scale

A lower score indicates better sustainability












Exposure refers to the extent to which a company is exposed to different material ESG issues



Management is related to actions taken to manage ESG issues


Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.


Covered Companies

00 of 16,421






00 of 928






0. of 456




To view GSK’s complete esg history, request access »

GSK Exits (67)

Company Name Exit Date Exit Type Exit Size Status Buyers
WaVe Life Sciences 13-Dec-2022 0000 00.00 Completed
  • 000
CalciMedica 11-Mar-2021 00000 00000 00 0000 Completed
  • 9 buyers
Insmed Innovation 18-Dec-2020 00000 00000 00 00.00 Completed
  • 2 buyers
IDEAYA Biosciences 03-Aug-2020 0000 0000 Completed
  • 000
SpringWorks Therapeutics 29-Mar-2019 Early Stage VC 00000 Completed
  • 15 buyers
You’re viewing 5 of 67 exits. Get the full list »


  • Who is the CEO of GSK?

    Emma Walmsley is the CEO of GSK.

  • Where is GSK headquartered?

    GSK is headquartered in Middlesex, United Kingdom.

  • What is the size of GSK?

    GSK has 70,200 total employees.

  • What industry is GSK in?

    GSK’s primary industry is Pharmaceuticals.

  • Is GSK a private or public company?

    GSK is a Public company.

  • What is GSK’s stock symbol?

    The ticker symbol for GSK is GSK.

  • What is the current stock price of GSK?

    As of 24-May-2024 the stock price of GSK is $22.52.

  • What is the current market cap of GSK?

    The current market capitalization of GSK is $93.4B.

  • What is GSK’s current revenue?

    The trailing twelve month revenue for GSK is $38.6B.

  • Who are GSK’s competitors?

    AstraZeneca, Novartis, Merck & Co., Pfizer (Pharmaceuticals), and Emergent BioSolutions are some of the 33 competitors of GSK.

  • What is GSK’s annual earnings per share (EPS)?

    GSK’s EPS for 12 months was $1.29.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »